INCY - Incyte Non-GAAP EPS of $0.64 misses by $0.19 revenue of $880.89M misses by $43.75M
2024-04-30 07:03:19 ET
More on Incyte
- Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade)
- Incyte: A Potential GARP Superstar
- Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript
- Incyte Q1 2024 Earnings Preview
- Incyte to acquire immune-focused drug developer Escient